Alternatives to Citeline

Numerous organizations globally rely on IQVIA to accelerate the drug development process, guarantee the safety and quality of products, enhance commercial efficacy, deliver appropriate treatments to patients, and ultimately promote improved health outcomes by facilitating access to and delivery of healthcare. Transform your approach to clinical development by seamlessly integrating data, technology, and analytics to streamline your trials. The outcome? Quicker decision-making and minimized risks, enabling you to provide transformative therapies at a faster pace. With its expertise rooted in data, sophisticated analytics, and deep industry knowledge, IQVIA offers tailored capabilities to clients throughout the healthcare landscape. Stay informed by exploring the latest insights and updates from IQVIA's data scientists, healthcare professionals, researchers, and other industry experts on crucial topics that resonate with your interests. From emerging industry developments to practical applications of our capabilities, a wealth of information awaits you here. Engaging with this content also empowers you to stay ahead in a rapidly evolving healthcare environment.

Medrio's Electronic Data Capture (EDC) platform and complimenting eClinical solutions such as ePRO, RTSM, eConsent, and Direct Data Capture (DDC) have been trusted by major pharmaceutical, biotech, CRO, animal health, medical device, and diagnostic companies since 2005. We are known for our easy-to-use solutions, delivering speed and simplicity to clinical trials of all phases, sizes, and complexities. Medrio users can build their databases in an average of 2.8 weeks with no programming required, make mid-study changes with just a few clicks of a mouse, and much more. From bolt-on capabilities to full-service offerings, Medrio offers flexible, modular solutions that give our customers exactly what they need – and none of what they don’t. Our innovative software, as well as the robust and flexible training and support resources we provide our customers, have earned us a 98% customer satisfaction rating.

Biorce’s Aika represents a groundbreaking AI-driven clinical intelligence platform that enhances every phase of the clinical trial lifecycle by transforming slow, manual processes for protocol development and feasibility assessments into efficient, evidence-based automation. Leveraging insights from approximately one million real-world trials, Aika can swiftly produce first-draft study protocols, comprehensive regulatory documentation, site feasibility evaluations, risk management strategies, and other critical trial components significantly faster than conventional approaches, which helps in minimizing delays and expensive modifications. Aika not only ensures complete transparency in its recommendation processes, allowing teams to confidently communicate their decisions to regulators while retaining expert oversight, but also effectively combines the rapid capabilities of AI with the depth of clinical knowledge. By drastically reducing trial preparation times from weeks to mere days, it significantly decreases the chances of amendments and mitigates overall risk, all while seamlessly fitting into existing workflows without the need for extensive retraining. With Aika, clinical trial teams can focus more on strategic decision-making rather than being bogged down by administrative tasks.

The Medidata Clinical Cloud represents our innovative platform designed to revolutionize the clinical trial journey for patients, sponsors, CROs, and research institutions. As the sole comprehensive technology solution focused exclusively on clinical research, the Medidata Clinical Cloud addresses the entire research spectrum from inception to completion. Our platform enables organizations in the life sciences and medical device sectors to reduce development expenses, manage risks effectively, and expedite the introduction of treatments and devices to the marketplace. Whatever selection you make for your clinical trial initiatives, you will benefit from the capabilities of the Medidata Clinical Cloud. At Medidata, we are at the forefront of the digital evolution in clinical research. With the power of artificial intelligence, machine learning, and sophisticated analytics, our platform connects researchers, study coordinators, investigators, and patients, thereby hastening the research process. Additionally, it provides a regulatory-compliant, patient-friendly electronic informed consent solution for clinical trials, ensuring a smoother experience for all parties involved. This integration of advanced technology not only streamlines operations but also enhances the overall quality of clinical research.

Agatha provides a comprehensive range of cloud-based solutions specifically designed for the life sciences sector, facilitating the centralized oversight of documents and processes related to clinical operations, quality assurance, regulatory compliance, and training activities. This platform caters to the workflows of biotech firms, pharmaceutical companies, medical device manufacturers, and contract research organizations by offering various modules, including eTMF (Inspection-Ready Master Trial File), Remote ISF (Investigator Site File) management, and tools for creating and approving standard operating procedures (SOPs) as well as managing quality documents related to CAPAs, deviations, and change controls. Additionally, Agatha enhances regulatory document handling, ensuring smooth document creation, review, approval, storage, and sharing within a single cohesive system. By promoting a paperless approach, it alleviates administrative burdens and bolsters data security, while being constructed on a global-compliance framework that meets critical standards such as 21 CFR Part 11, GDPR, and EU Annex 11. Ultimately, Agatha empowers life sciences organizations to optimize their operations and maintain compliance with industry regulations more efficiently.

adWATCH - AE is a solution designed to aid pharmaceutical companies in handling and documenting adverse events that arise during clinical trials. It provides a quick and efficient way for reporters at clinics, hospitals, or investigative sites to create and oversee Adverse Event Reports (AERs), ensuring proper reporting to regulatory bodies and government organizations. An adverse effect refers to a harmful or undesirable reaction experienced by a patient due to medications or medical devices. The process of documenting adverse events necessitates thorough tracking of all medical complaint case details, which culminates in the creation of MedWatch reports, CIOMS reports, and other management documentation. With adWATCH - AE, researchers, physician investigators, Contract Research Organizations (CROs), clinical trial experts, and various health professionals can easily generate and submit AERs in compliance with FDA requirements, adhering to both MedWatch and CIOMS formats. This streamlined process not only enhances regulatory compliance but also improves patient safety oversight during clinical trials.

H1 is an international company specializing in healthcare data technology, offering a robust platform that provides in-depth insights into the healthcare sector by analyzing data from more than 11 million healthcare professionals. The solutions provided by H1 are tailored to enhance the effectiveness of medical affairs, clinical trials, and commercial teams by supplying immediate access to healthcare professional insights and AI-driven analytics, which ultimately lead to meaningful interactions and expedite the process of developing and distributing life-saving therapies. With an expansive database that features over 160 million peer-reviewed articles, 350,000 clinical trials, and 8 billion medical claims, clients can pinpoint key opinion leaders, streamline the selection of clinical trial sites, and connect with suitable prescribers to guarantee that patients obtain the correct treatments. Moreover, H1 ensures that organizations can comply with risk, compliance, and disclosure standards effortlessly. Every action taken is meticulously captured in real-time activity logs, enhancing transparency and accountability within the platform. This commitment to comprehensive data management empowers healthcare professionals to make informed decisions that positively impact patient outcomes.

Streamline your localization efforts by eliminating inefficiencies, reducing complexity, and getting rid of repetitive manual tasks through the comprehensive Lionbridge Translation Management Platform, which allows you to automate workflows, monitor tasks, and access project status updates from a single online hub for all your translation initiatives. It is crucial to ensure that your highly regulated content adheres to necessary regulatory standards while also appealing to audiences around the globe. Lionbridge offers tailored solutions for various sectors, including legal, financial, and life sciences translation services. Our expert teams specializing in clinical trial translations are equipped to handle a wide array of documents associated with clinical trials, covering scientific, medical, legal, or layman language. Furthermore, we meticulously translate and validate all types of labels for investigational drugs, including placebos, comparator drugs, and auxiliary medicinal products used in clinical protocols. By leveraging our services, you can enhance the accuracy and effectiveness of your translations, ensuring compliance and clarity across diverse markets.

Marvin is a software platform that provides solutions for Clinical Data Management. This includes EDC (including IWRS/Drug Management and WebPRO), reporting, and more. ), Coding and Composer (CDISC ODM based study design including SDTM map), SDTM visualization, Clinical Document Management, (eTMF), and a mobile app for direct communication between Investigators & patients. Our software and technical support help accelerate clinical trials around the world. Founded in 2002, XClinical is an international eClinical vendor. Marvin, the company's software platform, provides solutions for Clinical Data Management such as EDC (including IWRS/Drug Management and WebPRO), reporting, and more. ), Coding and Composer (CDISC ODM based study design including SDTM map), SDTM visualization, Clinical Document Management, (eTMF), and a mobile app for direct communication between Investigators & patients. Our software and technical support help accelerate clinical trials around the world.

Effectively monitor clinical trials from start to finish with Ennov’s comprehensive Clinical Trial Management software. Each year, clinical trial sponsors search for new ways to improve the efficiency and reduce the costs associated with running their trials. Investigational site efficiency and productivity can be improved by centralizing information, actively monitoring progress, automating schedules, managing finances, and providing accurate reporting and metrics. With the Ennov CTMS, trial sponsors and CROs are able to actively address all aspects of trial management from a single platform: investigator sites, patients, SAEs, deviations, inclusions, visit reports, phone contacts, investigational product management, trial facilities, and finances. Study managers can plan and track their trials in real time to make better decisions faster. With the Ennov CTMS dashboard functionality, study personnel get on-demand analytics to improve quality, control risk, and reduce costs.

Our platform, designed with regulatory compliance in mind, enhances clinical research by using algorithms to sift through unstructured EMR data to identify life-threatening conditions. We create cutting-edge technologies that broaden access to groundbreaking healthcare solutions through Clinical Trials. Our dedicated team is committed to saving lives by facilitating access to therapeutic innovations that are still being researched. We strongly advocate that every patient should be informed and empowered regarding their potential to engage in clinical trials that could offer significant therapeutic benefits. As a forward-thinking healthcare AI research firm, we have created a computational platform that identifies patients who meet a detailed set of criteria for participation in clinical trials, ensuring that the most suitable candidates are considered for these critical studies. Through our work, we aim to revolutionize the way patients connect with life-changing treatment opportunities.

At ePharmaSolutions, we are pioneering innovative approaches. While we don't classify ourselves as a high-tech firm, our foundation is built on ideas that are deeply rooted in technology yet not confined by it. We enhance the drug development landscape by offering solutions that streamline the processes of identifying, activating, training, and managing clinical trial sites. By viewing traditional challenges through a new lens, we provide technology-driven solutions designed to simplify the complexities of clinical trial management. ePharmaSolutions (ePS) stands out as a premier provider of e-clinical solutions that transform the methods of selecting, training, activating, and overseeing clinical trial sites. By infusing fresh perspectives into longstanding issues, we create innovative, technology-facilitated solutions that enable sponsors, contract research organizations, and investigator sites to effectively navigate and simplify the intricacies of clinical trial management. Our commitment to redefining these processes ensures that we remain at the forefront of the industry, continually adapting to meet evolving needs.

Precision, efficiency, and assurance. The integration of generative AI into the biopharmaceutical industry is here. This technology streamlines the arduous task of gathering, organizing, and analyzing extensive data sets. Achieve essential insights with complete assurance every single time. With our AI-driven platform for data handling and validation, you will keep your workflows organized effortlessly. Collect, process, and verify your data all from a single interface. Easily search through both public and private databases using key characteristics of drugs. Categorize drugs and clinical trials based on comprehensive patient demographics. Retrieve necessary data in straightforward language. Strengthen your conclusions by linking your findings to their original sources. Direct your focus towards creating valuable outputs from your data, bypassing the tedious manual sorting process. Our advanced language models empower researchers to conduct asset evaluations 4.8 times quicker than traditional methods. We provide access to an extensive index of over 38 million scientific articles, conference papers, and clinical trial data. With this system, you’ll have all the information you require at your fingertips, ensuring timely and informed decision-making. Additionally, our platform adapts to your unique needs, enhancing the research experience even further.

Signant Health operates as a worldwide leader in evidence generation, striving to transform the landscape of clinical trials by connecting with patients in their environments and rethinking the route to validation. Their extensive range of clinical technology solutions includes electronic Clinical Outcome Assessments (eCOA), Electronic Data Capture (EDC), electronic clinician evaluations, and a cohesive eClinical platform. Additionally, they offer patient engagement solutions featuring a user-friendly app, eConsent for informed consent processes, and telemedicine functionalities. Furthermore, Signant Health delivers clinical data and analytics services, which include COA data analysis as well as the aggregation and interpretation of data. With a rich history spanning over three decades, they have played an instrumental role in supporting numerous trials and have been pivotal in hundreds of drug approvals, establishing themselves as a reliable ally for sponsors and CROs eager to provide high-quality data for informed trial decisions and regulatory submissions. Their commitment to innovation continues to shape the future of clinical research.

Folio3 Digital Health offers an all-encompassing Clinical Trial Management Software (CTMS) that is a web-based solution aimed at enhancing the efficiency of the entire clinical trial lifecycle for pharmaceutical firms, contract research organizations (CROs), and research institutions. This platform consolidates various trial operations, facilitating everything from planning and site oversight to data gathering and reporting, while ensuring adherence to international regulations such as FDA 21 CFR Part 11, GxP, and HIPAA. With a focus on delivering user-friendly interface designs, real-time dashboards, and adaptable modules, the software is capable of managing clinical trials of any scale effectively. The system includes specialized modules for study initiation, allowing users to outline protocols, timelines, and budgets using customizable templates tailored to their needs. Moreover, the site management features enable tracking of investigator credentials, contracts, and financial transactions, in addition to patient recruitment tools that streamline screening, monitoring of enrollment, and scheduling of visits, complete with automated reminders to enhance participant engagement. Notably, the platform’s versatility makes it suitable for various stakeholders involved in clinical research, thereby promoting a more integrated and efficient trial management experience.

BEKhealth provides an innovative clinical research platform, known as the BEKplatform, which leverages artificial intelligence to streamline the extraction, interpretation, and standardization of both structured and unstructured electronic medical record data, encompassing various elements such as lab results, diagnoses, physician notes, pathology reports, and PDFs. This integrated system creates a searchable, longitudinal patient graph designed to assist life sciences and healthcare organizations in swiftly pinpointing protocol-eligible patients while enhancing trial feasibility, site selection, and recruitment processes. By utilizing advanced deep learning techniques and natural language processing, BEKhealth transforms chaotic clinical data into precise, actionable insights, allowing for the generation of sophisticated queries and patient cohorts. This method not only identifies more qualified candidates compared to traditional manual chart reviews but also provides real-time reports and dashboards that facilitate informed decision-making across research networks, ultimately improving the efficiency and effectiveness of clinical trials. The ability to generate these insights in real-time is a game-changer for organizations striving to maximize their research potential.

Historically, managing clinical trials at investigator sites involved either the cumbersome task of maintaining numerous shared spreadsheets or investing in costly software that often did not fit the Australian context. MAISi represents a revolutionary shift in this landscape. Originating in 2001 as a data repository for clinical trials at a prominent hospital, MAISi has transformed into an advanced workflow application designed to streamline various functions within research units. Serving as a centralized database, MAISi efficiently organizes information related to studies and the corresponding business units that manage them. This structured approach enhances management decision-making capabilities. Individual staff members within each business unit can access specific data pertaining to their studies, patients, investigators, and study team members, while those with broader access rights, typically Financial Officers and System Administrators, can view comprehensive data across all units. Additionally, this streamlined access promotes collaboration and improves overall operational efficiency.

AcceleTrial™ eliminates uncertainties in identifying and activating clinical trial sites. Our Study Start-up Management System (SSMS) relies on objective data rather than self-reported information. With AcceleTrial™, you gain access to a comprehensive database of thousands of globally ranked and indexed sites, evaluated based on their specific therapeutic expertise, clinical trial experience, and patient data. This system allows for an objective pairing of the most suitable sites worldwide with the relevant data on expertise, experience, and patient demographics for your clinical trials. You can swiftly engage the right sites to commence patient enrollment through AcceleTrial™'s automated “push and pull” functionality, available in multiple languages. The platform simplifies the process of gathering necessary documents with pre-filled templates and enables real-time tracking of activities. You can begin utilizing the system immediately, as it is a cloud-based solution that requires minimal IT infrastructure or training. Moreover, AcceleTrial™ can be seamlessly integrated with CTMS or other existing clinical trial management systems for enhanced efficiency. This ensures a streamlined approach to clinical trial management, allowing researchers to focus on their core objectives.

Flask Data equips life science research and development teams with timely clinical data and solutions for patient safety. The Flaskdata.io cloud API platform streamlines data collection applications for patients, researchers, site coordinators, connected devices, and pharmaceuticals. Our offerings in data management and safety oversight are designed to mitigate risks related to clinical data integrity, patient well-being, and adherence to protocols. The Flaskdata.io platform is not only automated but also scalable and responsive to the specific requirements of your clinical trials. Flask Data is a tech firm that focuses on clinical data oversight and management. We excel in delivering optimal solutions that ensure the highest quality of clinical data while prioritizing patient safety. Recognizing that there is no universal solution applicable to all clinical trials, we dedicate ourselves to thoroughly understanding your distinctive challenges. Collaborating closely with your team, we strive to create tailored solutions that meet your needs for high-quality clinical data and enhanced patient safety, ultimately driving the success of your research initiatives.

Suvoda is a worldwide leader in clinical trial technology, focusing on intricate, life-preserving studies in fields like oncology, central nervous system conditions, and rare diseases. Established in 2013, the company provides a comprehensive platform featuring Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all aimed at streamlining essential patient interactions. Their innovative software design guarantees a fluid user experience, enabling accurate randomization, efficient drug supply management, and immediate data collection. With a strong commitment to improving patient understanding and alleviating the demands on trial sites, Suvoda's offerings are designed to evolve alongside the increasing complexities of clinical trials. Based near Philadelphia, with additional offices across Europe and Asia, Suvoda has successfully supported over 1,500 trials in more than 85 countries, showcasing their global reach and expertise in the field. Their dedication to innovation and excellence positions them as a vital partner in the advancement of clinical research.

Noah AI serves as an advanced research assistant powered by artificial intelligence, specifically designed for professionals in the life sciences sector, with the goal of automating and expediting intricate workflows in biomedical research, clinical development, and strategic commercial planning. It features an “Agent” mode that efficiently manages and implements multi-step tasks through intelligent web searches, accessing credible scientific databases like PubMed and FDA/NIH resources, summarizing influential research papers, extracting data from clinical trials, and producing high-quality reports, while a simpler “Search” mode provides quick and trustworthy access to summaries of domain-specific content. By integrating extensive medical and public health data, alongside AI-generated insights and real-time tracking of global research and development activities as well as conference intelligence, Noah AI empowers researchers, biotech investors, and healthcare professionals to transform questions into insights significantly faster than traditional methods. This innovative approach not only enhances productivity but also fosters a more informed decision-making process in the ever-evolving landscape of life sciences.

The LARVOL CLIN platform offers a robust suite of AI-driven data intelligence and analytics specifically designed for professionals in oncology and drug development, consolidating over 100,000 cancer clinical trials along with comprehensive results, digitized Kaplan-Meier curves, forest plots, and live social media feedback from a network of more than 5,000 oncologists. Users benefit from a unified interface that allows for searches by condition, intervention, or trial ID, complemented by expert-curated insights and visually engaging dashboards that facilitate informed decision-making. Additionally, the platform encompasses features such as conference tracking, extensive biomarker and diagnostics databases, and market intelligence reports sourced from over 25,000 entities, including regulatory communications, clinical trial registries, and various scientific congresses. Designed to aid pharmaceutical and biotech teams in deciphering trial outcomes, trends, mechanisms of action, biomarker identification, and disease pipelines, it employs advanced search filters, heat maps, and real-time alerts. This comprehensive approach ensures that users remain well-informed and equipped to make strategic decisions in a rapidly evolving field.

Most Easy-to-Use Clinical Trial Management System (CTMS) 𝐂𝐥𝐢𝐧𝐢𝐨𝐧 𝐂𝐓𝐌𝐒 integrates seamlessly with Clinion EDC and Clinion RTSM to provide detailed and faster access to the entire trial process to address all aspects of Clinical trial management from a single platform: investigator sites, patients enrollment, SAEs, deviations, inclusions, visit scheduling, IP management, milestones, finances, custom reports, and on-demand analytics enables you to improve quality, control risk, and reduce costs. Clinion CTMS is modular in design These modules are available: Admin Module Project Management Site Monitoring Activities Finance and Budget Management Safety Reporting Management of IP Inventory Document Management System Audit/Activity Log Comprehensive dashboards Comprehensive Reports

Salesforce Agentforce Life Sciences is a comprehensive CRM platform designed to support the entire life sciences value chain. It connects clinical development, medical affairs, commercial operations, and patient services within a unified and compliant ecosystem. Built on Salesforce’s deeply integrated platform, it ensures regulatory requirements are embedded into workflows. AI-driven agents assist with clinical trial recruitment, participant management, and predictive enrollment analytics. Medical affairs teams can automate inquiry responses and manage scientific knowledge exchange more efficiently. Commercial teams gain a unified view of healthcare professionals to deliver personalized, omnichannel engagement. The platform enhances patient services with automated insurance verification and proactive support programs. Real-time dashboards provide actionable insights across stakeholders and operations. Integration with Data 360, MuleSoft, Tableau, Slack, and Health Cloud expands collaboration and analytics capabilities. Agentforce Life Sciences empowers organizations to accelerate innovation, improve compliance, and drive better health outcomes.

Cloudbyz Safety & Pharmacovigilance Solution, a cloud-based solution, is designed to streamline drug safety and pharmacovigilance for pharmaceutical and life sciences companies. The solution automates the process of collecting data, processing it, analyzing it and reporting it in compliance with global regulations. Cloudbyz provides end-to-end management of the pharmacovigilance lifecycle, including adverse event processing, case management, regulatory reporting, signal detection, and risk management. With Cloudbyz, you can optimize your pharmacovigilance processes, accelerate case processing, and increase the accuracy of your safety data, while minimizing risk and ensuring compliance. The benefits of our solution are listed below- 1. Improved Efficiency with Automation 2. Increased data accuracy 3. Real-time visibility 4. Improved Collaboration 5. Enhanced regulatory compliance

In recent years, the Life Sciences sector has incurred nearly $15 billion in fines and settlements related to compliance, underscoring the importance for firms to follow best practices in pharmaceuticals, medical devices, and biotechnology. Additionally, the way clinical trials are managed can greatly influence the timeline, scope, and financial resources allocated for the development of drugs or medical devices. Utilizing OpenText™ Clinical Trial Quality Management System (ctQMS) allows organizations to maintain compliance, lower record management expenses, and foster collaboration to implement best practices throughout the entire clinical trial lifecycle. This strategic approach not only enhances operational efficiency but also contributes to the overall success of product development initiatives.

ImproWise is an entirely web-based platform that guarantees security and HIPAA compliance, specifically designed for comprehensive Clinical Trial Management (CTMS) and Clinical Data Management (CDMS). This innovative solution delivers unmatched flexibility, rapid performance, and robust security by integrating functionalities such as CTMS, CDMS, EDC, CTBM, CTPM, eTMF, ePRO, and RBACS. Tailored to address the requirements of all parties involved in clinical trials, ImproWise facilitates smooth collaboration among sponsors, investigators, data managers, data entry specialists, site personnel, and regulatory affairs experts, ultimately enhancing efficiency throughout the entire trial process. Furthermore, the platform's user-friendly interface makes it accessible for users of varying technical backgrounds, ensuring that everyone can contribute effectively to the trials.

Cytel stands out as a prominent global innovator in software for clinical trial design, biometrics, and advanced analytics, focusing on maximizing the efficiency of clinical trials while aiding pharmaceutical companies in harnessing the full scope of both clinical and real-world data. Established in 1987 by renowned statisticians Cyrus Mehta and Nitin Patel, Cytel has consistently been a leader in adaptive clinical trial technology and the field of biostatistics. Its software solutions, notably the East Horizon platform, facilitate accurate trial design and simulation, employing adaptive and Bayesian methodologies to enhance protocols and expedite the drug development process. The East Horizon platform serves as a comprehensive integration of Cytel's reliable software offerings, featuring R integration that significantly improves trial design functions. Furthermore, Cytel provides the Xact software suite, which is an all-encompassing toolkit designed for statistical analysis of small datasets, including those with sparse and missing data. By continuously innovating and expanding its product offerings, Cytel remains committed to providing cutting-edge solutions that meet the evolving needs of clinical research.

We are developing a worldwide marketplace for clinical trials aimed at enhancing visibility, accessibility, and involvement among a more varied group of healthcare professionals and their patients. At Inato, our goal is to ensure that clinical research is available to every patient, no matter their identity or location. Marketplaces have shown to be revolutionary in expanding access to various services, and we are convinced that we can replicate this success in the realm of clinical research. We illuminate the numerous community sites globally that are eager to provide additional trials for their patients, while also assisting them in realizing their full research capabilities. By effectively pairing the appropriate sites with suitable trials on an international scale, we streamline the process for all involved. Our comprehensive support model guarantees that sponsors can confidently collaborate with a diverse array of sites worldwide, thereby matching research locations to the ideal clinical trial protocols and unlocking their potential on a global stage. This approach not only benefits the sites and sponsors but ultimately enhances the experience and outcomes for patients participating in clinical trials.

Basil harnesses cutting-edge AI and machine learning technologies to significantly enhance access to critical insights that are essential for successful medical product development. Through a robust SaaS platform, Basil reveals intelligence hidden within various disconnected data sources, enabling quicker decision-making that accelerates market entry, refines product strategy, fosters innovation, and reduces risks. This innovative approach allows for a remarkable increase in efficiency when it comes to identifying insights and formulating regulatory strategies. Additionally, users can uncover crucial, previously inaccessible in-market quality and surveillance insights, along with valuable trends and analytics. With access to over 500,000 trials, Basil empowers users to thoroughly find, explore, and analyze existing clinical evidence for a comprehensive understanding of the landscape. Ultimately, this transforms the way organizations navigate the complexities of medical product development.

Altis Labs has unveiled Nota, a groundbreaking clinical information platform designed to expedite therapeutic research and development. By harnessing the power of AI, Nota can forecast patient outcomes based on imaging data, allowing sponsors to efficiently prioritize their most promising therapies. This innovative platform empowers researchers to effectively utilize clinical trial imaging data, gain access to predictive imaging biomarkers, and enhance R&D efforts on a larger scale. With Altis’ cloud-based software, which employs advanced deep learning techniques, biopharma companies can integrate detailed outcome predictions at the image, patient, and cohort levels, ultimately refining clinical trial design and boosting confidence in anticipating clinical endpoints. The insights generated by Nota have the potential to drastically shorten development timelines, reduce drug development expenses, and increase the chances of success across various therapeutic areas, paving the way for a new era in clinical research. As the demand for efficient drug development continues to rise, Nota stands out as a vital tool for the biopharmaceutical industry.

Quva BrightStream is an advanced cloud-based platform tailored for the operational needs of health-system pharmacies, which consolidates, standardizes, and integrates clinical as well as operational data from various care sites to provide prioritized and quantified insights. This platform features AI and machine learning capabilities through modules like Shortage Navigator for anticipating supply chain shortages, Diversion Surveillance for monitoring drug diversion, Supply Advisor for aligning inventory with patient needs, Script Revenue Capture for identifying lost prescription revenue, Contracts Value Maximizer for ensuring compliance and optimizing price performance, and Clinical Process Optimizer for managing order sets, formularies, and protocols. In addition, it offers dashboards for senior leadership that provide a comprehensive view while allowing detailed exploration of key opportunities such as cost savings, inventory efficiency, diversion management, and revenue enhancement. Furthermore, it is backed by demonstrated success within the community, showcasing its effectiveness in real-world applications. Overall, Quva BrightStream empowers pharmacy operations with data-driven insights that can significantly enhance decision-making processes.

Replior is a pioneering company specializing in software solutions for clinical trials, featuring an integrated platform that encompasses EDC, eConsent, ePRO, and Virtual Visits to enhance trial execution. Our comprehensive system, known as Trial Online, facilitates the seamless collection and management of data from investigators, participants, and wearable devices in an efficient manner. It is designed to accommodate decentralized clinical trials (DCT), allowing for flexibility with site visits, remote interactions, or a combination of both. Our journey commenced two decades ago when we were approached to create an online CRF service for a major pharmaceutical firm, marking our transition from an IT operations provider to a dedicated software developer for clinical data collection. Over the years, we have expanded our offerings to include a complete suite of data collection services, while our IT operations are expertly managed by our highly qualified sister company, Complior. As we continue to innovate, our commitment to enhancing clinical trial processes remains at the forefront of our mission.

Jeeva's patent-pending modular system is built on the most powerful cloud platform. One login from any browser-enabled device can be used to remotely screen patients, educate, enroll, send SMS, email and generate evidence including electronic patient-reported outcomes. They are tired of waiting for patient recruitment and retention to happen. It is crucial to provide sufficient evidence of safety and efficacy for investigational new medicines in order to receive regulatory agency approval. Jeeva is a great tool for saving time and money for patients, biopharma sponsors, and long-term follow up studies for gene therapy.

TriNetX operates as a worldwide health research network that links healthcare institutions with life sciences firms to enhance real-world research and expedite the creation of innovative therapies. Utilizing a self-service platform that adheres to HIPAA, GDPR, and LGPD regulations, TriNetX allows users to tap into federated electronic health records, various datasets, and consulting collaborations. This capability empowers the global research community to enhance protocol design, optimize trial operations, improve safety signal assessments, and amplify the generation of real-world evidence. The network boasts a comprehensive dataset representing over 275 million patients from 150 healthcare organizations across 25 nations, thereby offering a rich resource for research endeavors. Researchers have taken advantage of the TriNetX network to examine upwards of 26,000 protocols and present more than 7,000 clinical trial opportunities to the healthcare members, thereby cutting site identification time for clinical trials by an impressive 50%. In doing so, TriNetX not only fosters collaboration among entities but also catalyzes advancements in medical research and patient care worldwide.

We create innovative solutions that enhance and strengthen the clinical trial ecosystem. Our platform for Enrollment Performance Management is favored by research sites and relied upon by sponsors. It is utilized by 2,000 research sites in 26 countries and is endorsed by half of the world's top-20 biopharma companies. This enables sites to reduce time spent on repetitive and manual activities, facilitating a smoother patient progression. By minimizing redundant efforts, there are fewer logs, phone calls, and emails required from both sites and sponsors. Sponsors can proactively improve enrollment with immediate access to advanced pre-screening and enrollment metrics. Our remarkably straightforward patient recruitment and enrollment solution is trusted by over 1,800 sites worldwide. Gain access to impactful recruitment and enrollment insights, ensuring clinical trials are conducted faster and with greater predictability. By eliminating unnecessary tasks, sites can refocus their efforts on what truly matters: providing assistance to patients. Effortlessly manage recruitment across all trials, sponsors, or CROs with the ability to input information once and have it directed where it is needed most. This innovative approach not only streamlines the process but also enhances collaboration among all stakeholders involved in clinical trials.

cubeCTMS is an all-encompassing clinical-trial management platform that facilitates complete oversight of trials, encompassing aspects such as tracking study sites and investigators, managing enrollment and visit schedules, and overseeing budget and contract workflows, as well as milestone reporting and document management. By centralizing study operations and automating essential processes, it allows sponsors, CROs, and study teams to oversee progress in real time, coordinate tasks across various studies, enhance communication with sites, and reduce risks. The platform offers integrated dashboards, notifications, and audit-ready documentation to ensure compliance with regulatory standards, including readiness for FDA 21 CFR Part 11, empowering stakeholders to oversee trial timelines, resources, and overall performance from a singular interface. Additionally, cubeCTMS seamlessly connects with other CRScube modules, such as EDC, eTMF, and pharmacy/RTSM, creating a cohesive ecosystem that minimizes redundancy, optimizes data flow, and supports flexible workflows during amendments or large-scale implementations. This integration not only streamlines processes but also enhances the overall efficiency of clinical trials, making it an invaluable tool for research teams.

Deep 6 AI revolutionizes the patient enrollment process for clinical trials by changing how researchers pinpoint suitable candidates. By leveraging artificial intelligence and natural language processing, DEEP 6 AI efficiently sifts through both structured and unstructured patient information, enabling the identification of a larger pool of well-matched trial participants in mere minutes instead of the months typically required. The platform collaborates with leading health systems, pharmaceutical companies, and contract research organizations, positioning itself as an essential component of the clinical research ecosystem and significantly hastening the process for patients to access trials. In addition to expediting enrollment, Deep 6 AI’s innovative software evaluates structured data, like ICD-10 codes, alongside unstructured clinical information such as physician notes, pathology reports, and surgical documents that are often difficult to search through. This comprehensive analysis ensures that researchers can quickly find candidates who meet specific criteria, ultimately leading to faster delivery of groundbreaking treatments to those in need.

Progressing artificial intelligence to remove the need for trial and error in healthcare, our digital twins facilitate swift and assured clinical trials. We focus on areas such as neuroscience, immunology, and metabolic diseases, among others. TwinRCTs expedite full enrollment by requiring fewer participants to provide equivalent statistical power compared to conventional trial methodologies. This approach significantly reduces the time needed for late-stage study enrollment. Additionally, TwinRCTs enhance the ability to detect treatment effects in early-stage studies by bolstering statistical power without necessitating an increase in participant numbers. They enable researchers to make informed decisions based on initial study outcomes and help attract more participants to trials. By utilizing smaller control groups, TwinRCTs also improve participants' odds of receiving the experimental treatment. Our commitment to positioning clinical trials with digital twins for regulatory success is unwavering. Unlearn is at the forefront of transforming the medical field through the innovative application of artificial intelligence, creating and implementing novel generative models that are trained on vast datasets derived from previous patient studies. This evolution in methodology not only streamlines research but also enhances the overall effectiveness of clinical trials.

Verana Health operates as a platform for real-world data that converts both structured and unstructured information from electronic health records into curated, de-identified, disease-focused data modules through its clinician-informed and AI-enhanced VeraQ population health data engine. By aggregating data from key collaborations with prominent medical registries, including the American Academies of Ophthalmology, Neurology, and Urological Association, the platform integrates insights from over 20,000 clinicians and approximately 90 million patient records, thereby supplying high-quality datasets in near real-time for the purposes of generating real-world evidence, identifying clinical trial sites and subjects, reporting clinician quality, and managing medical registries. Users can access this wealth of information through cloud services like AWS Data Exchange and Amazon Redshift, which provide self-service API access, a user-friendly dashboard, and tools for customizable cohort discovery. Furthermore, the system employs advanced AI and machine learning algorithms along with comprehensive data quality assessments to ensure the reliability and accuracy of the information provided. This innovative approach not only facilitates efficient data utilization but also enhances the overall quality of healthcare research and practice.

REDCap Cloud serves as a comprehensive data-science platform that empowers organizations to gather, integrate, standardize, analyze, and disseminate clinical and research data that meets real-world and regulatory standards, all within a cohesive, standards-driven system. This platform facilitates the complete lifecycle of randomized clinical trials and real-world evidence research by providing diverse modules tailored for intricate trial design and execution, a centralized clinical data hub that integrates both eCRF and non-eCRF sources, AI/ML capabilities for real-time operational and data insights, and seamless connectivity to eSource and EHR systems. Additionally, it enhances patient engagement through tools like ePRO/eCOA and wearable devices, accommodating both hybrid and decentralized trial models. The analytics features include options for synthetic control arms and digital twins, ensuring adherence to global security compliance standards. Ultimately, REDCap Cloud is designed to mitigate data silos, eliminate vendor fragmentation, facilitate bidirectional data flows, and offer sponsors, CROs, and health systems comprehensive visibility and oversight regarding site performance, study data integrity, and regulatory preparedness. By streamlining these processes, organizations can achieve greater efficiency and effectiveness in their research endeavors.

Experience the forefront of eSource, CTMS, and eRegulatory software designed specifically for clinical trial sites. With CRIO’s top-tier electronic source, you can effortlessly capture source data in real-time, drastically cutting down on paper usage by up to 90% while enhancing data quality by 80%. Gain command over your operations through CRIO’s user-friendly Clinical Trial Management System, allowing you to efficiently schedule patients, monitor financials, and optimize recruiting processes. We proudly present cutting-edge electronic regulatory binders, including the innovative first-ever electronic delegation log, all compliant with 21 CFR Part 11 standards. For clinical trial sponsors, you can perform 100% remote monitoring of your sites’ source data and regulatory documents through a secure online portal. Become a part of our extensive network of over 500 clinical research sites worldwide. Our commitment is to facilitate the growth of your business by streamlining your site’s operations, ensuring that your studies can continue smoothly, regardless of whether you're on-site or not. This way, you can focus on what truly matters: advancing your clinical research initiatives.

DrugDev Spark™ stands out as the first all-encompassing unified clinical operations suite globally. Delve into our offerings below to discover the reasons behind the trust placed in DrugDev technology by numerous sponsors, including 9 out of the top 10, and CROs, with 4 of the top 5 relying on our services. This groundbreaking platform merges cutting-edge technology with expert services, demonstrating its value across thousands of clinical trials. Our solutions, meticulously tested and refined by sponsors, CROs, and sites of various scales in over 60 countries, encompass every aspect from planning to closeout. Our extensive experience has enabled us to incorporate best practices into every feature of our system. Consequently, it’s no surprise that leading organizations, including 9 of the top 10 pharmaceuticals and 4 of the top 5 CROs, trust DrugDev technology. The collaboration fostered by our solutions is transforming the landscape of clinical trials, facilitating more efficient and effective processes for sponsors and CROs alike. Many of the world’s foremost sponsors and CROs are leveraging DrugDev solutions to revolutionize their approach to conducting clinical trials through enhanced teamwork and innovation.

VIPER streamlines the process of screening by automating remote patient identification right at the diagnosis stage and ensuring qualified enrollment. By leveraging artificial intelligence, VIPER efficiently matches patients to precision trials during a critical enrollment period by utilizing lab-agnostic genomic data, electronic medical records (EMR), and pathology information tailored to both the patient and the research requirements. The system employs a specialized matching engine that searches for the most suitable clinical trials corresponding to a patient's specific diagnosis at the moment they receive it. Additionally, through seamless workflow integration, VIPER provides real-time alerts regarding a patient’s eligibility for available trials, ensuring the entire care team is informed during this narrow enrollment timeframe. Furthermore, VIPER features interactive dashboards that offer extensive data mining capabilities, allowing for the aggregation of site and study-level patient data to effectively meet study key performance indicators (KPIs). This comprehensive approach not only enhances trial recruitment efficiency but also supports researchers in achieving their goals more effectively.

At Genospace, we recognize that the evolution of precision medicine is being propelled by advancements in genomics, yet the challenge of effectively scaling its implementation remains unresolved. Our mission is to bridge this gap. Our innovative platform aims to transform biomedical data into valuable insights that are easily accessible for all, particularly for those actively involved in delivering care. Equip your clinicians and researchers with essential information that empowers them to make well-informed choices while participating in our goal of utilizing intricate molecular data to enhance patient outcomes and speed up the processes of drug development and research. In this context, the significance of large-scale population data for drug discovery and research cannot be overstated. Utilize cohort-driven analyses through the Genospace platform to support your research initiatives. We have a strong focus on clinical trial research, enabling the Genospace platform to seamlessly align fragmented patient information with intricate trial requirements, thus facilitating quicker patient recruitment. Furthermore, our platform is designed to integrate genomic medicine into standard clinical care practices, making it easier than ever to harness the power of genomics in everyday healthcare. Together, we can push the boundaries of what’s possible in patient care and research.